Journal of Neuroscience · 2019 · 115 citations · 53 references
Life SciencesNeurobiologyNeuroscienceCellular NeuroscienceMolecular NeurobiologyMolecular NeuroscienceNeurodegenerative DiseasesNeurodegenerative DisordersNeurotransmissionProtein Aggregation DisordersSynaptic TransmissionSynaptogenesisActivity-dependent Synaptic ChangeAlpha-synuclein AggregationAlpha-synuclein MisfoldingDendritic SpinesHippocampal Neuron LossSynaptic Protein AggregationSynaptic StructureSynucleinopathy Models
Synucleinopathies are characterized by the accumulation of insoluble α-synuclein (αSyn). To test whether αSyn aggregates modulate synaptic activity, we used a recently developed model in primary neurons for inducing αSyn pathology. We demonstrated that preformed fibrils (PFFs) generated with recombinant human αSyn compromised synaptic activity in a time- and dose-dependent manner and that the magnitude of these deficits correlated with the formation of αSyn pathology in cultured excitatory hippocampal neurons from both sexes of mice. Remarkably, acute passive infusion of αSyn PFFs from whole-cell patch-clamp pipette decreased mEPSC frequency within 10 min followed by induction of αSyn pathology within 1 d. Moreover, by direct addition of αSyn PFFs into culture medium, the formation of misfolded αSyn inclusions dramatically compromised the colocalization of synaptic markers and altered dynamic changes of dendritic spines, but the viability of neurons was not affected up to 7 d post-treatment with αSyn PFFs. Our data indicate that intraneuronal αSyn fibrils impaired the initiation of synaptogenesis and their physiological functions, thereby suggesting that targeting synaptic dysfunction in synucleinopathies may provide a promising therapeutic direction. <b>SIGNIFICANCE STATEMENT</b> Under pathological conditions, the presynaptic protein α-synuclein (αSyn) aggregates to form intraneuronal inclusions. To understand how and to what extent αSyn aggregates modulate synaptic activity before neuron loss, we demonstrate that αSyn preformed fibrils (PFFs) reduced synaptic activity in a dose- and time-dependent manner. The magnitude of these deficits correlated with the deposition of αSyn pathology, which dramatically compromised the colocalization of synaptic markers and altered the dendritic spine dynamics. The present work further highlights the impact of αSyn PFFs on synaptogenesis and physiological function, which may be applicable to other types of synucleinopathies.
53
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Mihael H. Polymeropoulos, Christian Lavedan, Elisabeth Leroy et al. · Science · 1997 · 8.2K citations
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
J.J. Zarranz, Juan Carlos Gómez‐Esteban, Elena Lezcano et al. · Annals of Neurology · 2003 · 2.7K citations
Life Sciences, Genetics, Neurology +17
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
Jacqueline Burré, Manu Sharma, Theodoros Tsetsenis et al. · Science · 2010 · 1.8K citations · Full text
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Asa Abeliovich, Yvonne Schmitz, Isabel Fariñas et al. · Neuron · 2000 · 1.7K citations · Full text